NCT03749200 (OBEMAT20) is a NA clinical trial of Obemat2.0 therapy in Childhood Obesity, sponsored by Institut Investigacio Sanitaria Pere Virgili.

Who is sponsoring NCT03749200?

NCT03749200 is sponsored by Institut Investigacio Sanitaria Pere Virgili.

What drugs are being tested in NCT03749200?

Interventions in NCT03749200: Obemat2.0 therapy, Regular practise in primary care.

What condition does NCT03749200 study?

NCT03749200 studies Childhood Obesity, Metabolic Syndrome, Body Composition.

Is NCT03749200 still recruiting?

NCT03749200 is currently completed. Last updated 3 June 2024.

Last reviewed 2024-06-03 · How we verify

NCT03749200: OBEMAT20

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Motivational Approach to Treat Childhood Obesity

Completed NA Last updated 3 June 2024

What this trial tests

NA trial testing Obemat2.0 therapy in Childhood Obesity in 319 participants. Completed in 31 December 2021.

Timeline

1 January 2016

Primary endpoint
30 December 2020

31 December 2021

Quick facts

Lead sponsor	Institut Investigacio Sanitaria Pere Virgili
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	319
Start date	1 January 2016
Primary completion	30 December 2020
Estimated completion	31 December 2021
Sites	4 locations across Spain

Drugs / interventions tested

Obemat2.0 therapy
Regular practise in primary care

Conditions studied

Childhood Obesity — all drugs for Childhood Obesity →
Metabolic Syndrome — all drugs for Metabolic Syndrome →
Body Composition — all drugs for Body Composition →

Sponsor

Institut Investigacio Sanitaria Pere Virgili — full company profile →

Who can join

Adults 8 to 15, any sex, with Childhood Obesity or Metabolic Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The treatment of childhood obesity is challenging. Although dietary and physical activity recommendations are widely known, the willingness to change lifestyles within the family is not easy to be achieved. Motivational interviewing has been shown as a possibly effective method to increase adherence to dietary recommendations in the obese adult. There is scarce evidence showing whether implementing a motivational interview in obese children could be effective. The aim of this clinical trial is assessing the effect of a motivational interview, coordinated between the clinical and primary care services on 8 to 14 years old obese children.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

The Obemat2.0 Study: A Clinical Trial of a Motivational Intervention for Childhood Obesity Treatment.
Luque V, Feliu A, Escribano J, Ferré N, et al · · 2019 · cited 8× · PMID 30781525 · DOI 10.3390/nu11020419
Children's gut microbiota predicts the efficacy of obesity treatment.
Alcázar M, Luque V, Ferré N, Muñoz-Hernando J, et al · · 2026 · PMID 41711285 · DOI 10.1080/19490976.2026.2631824

Verify or expand the search:

Other trials of Obemat2.0 therapy

Trials testing the same drug.

NCT03749291 — Motivational Intervention on the Gut Microbiota of Obese Children · NA · completed

Other recruiting trials for Childhood Obesity

Currently open trials in the same condition.

NCT06836284 — The Evira Study: Additional Support During Obesity Treatment · NA · recruiting
NCT07467694 — Postnatal Exercise to Activate Baby's Brown Fat · NA · recruiting
NCT07184281 — Effectiveness of School-Based Time-Restricted Eating for the Prevention and Control of Obesity in Children · NA · recruiting
NCT07103343 — MOVI-OLE! [Open Learning Environments] · NA · active not recruiting
NCT06918821 — Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) Study · NA · recruiting

Other Institut Investigacio Sanitaria Pere Virgili trials

Trials by the same sponsor.

NCT07205978 — Nut Consumption and Prevention of Non-communicable Diseases: A Global Individual Participant Data Meta-analysis · active not recruiting
NCT07124923 — Continuous Care Intervention in Primary Care to Improve Type 2 Diabetes Control in Terres de l'Ebre, Catalonia · NA · recruiting
NCT07427056 — Impact of the War in Ukraine on the Mental Health of Refugees Residing in Spain · completed
NCT06775509 — Optical Quality of the Cornea in Orthokeratology · NA · active not recruiting
NCT06395246 — Circulating Microvesicles Regulating Metabolic Homeostasis in Obesity After Caloric Restriction Programs · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03749200 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut Investigacio Sanitaria Pere Virgili
Last refreshed: 3 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03749200.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing